Roseline d’Oiron

3.7k total citations · 1 hit paper
102 papers, 2.3k citations indexed

About

Roseline d’Oiron is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Roseline d’Oiron has authored 102 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Hematology, 30 papers in Genetics and 11 papers in Molecular Biology. Recurrent topics in Roseline d’Oiron's work include Hemophilia Treatment and Research (80 papers), Platelet Disorders and Treatments (48 papers) and Blood Coagulation and Thrombosis Mechanisms (30 papers). Roseline d’Oiron is often cited by papers focused on Hemophilia Treatment and Research (80 papers), Platelet Disorders and Treatments (48 papers) and Blood Coagulation and Thrombosis Mechanisms (30 papers). Roseline d’Oiron collaborates with scholars based in France, United Kingdom and Canada. Roseline d’Oiron's co-authors include M‐C. Poon, Giovanni Di Minno, Marc Jacquemin, Kathelijne Peerlinck, M.‐C. Poon, Claude Négrier, Jenny Goudemand, Renaud Lavend’homme, Rainer B. Zotz and Man‐Chiu Poon and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Roseline d’Oiron

95 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

International recommendations on the diagnosis and treatment of acquired hemophilia A

2020 183 citations Andreas Tiede, Jerome Teitel et al. Haematologica profile →

Peers

Countries citing papers authored by Roseline d’Oiron

Since Specialization

Citations

This map shows the geographic impact of Roseline d’Oiron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roseline d’Oiron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roseline d’Oiron more than expected).

Fields of papers citing papers by Roseline d’Oiron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roseline d’Oiron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roseline d’Oiron. The network helps show where Roseline d’Oiron may publish in the future.

Co-authorship network of co-authors of Roseline d’Oiron

This figure shows the co-authorship network connecting the top 25 collaborators of Roseline d’Oiron. A scholar is included among the top collaborators of Roseline d’Oiron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roseline d’Oiron. Roseline d’Oiron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	F8 gene variants influence the response to desmopressin in hemophilia A carriers 2025 ·Blood ·Benoît Guillet, Roseline d’Oiron, Marc Trossaërt, B. Wibaut, Brigitte Pan‐Petesch, (unknown), (unknown), (unknown), (unknown), Céline Falaise, Christine Biron‐Andréani, (unknown), Brigitte Tardy, (unknown), Hérvè Chambost, (unknown), (unknown), Xavier Delavenne	0
2	Acquired haemophilia A in paediatric patients: A retrospective French cohort of eight cases 2024 ·British Journal of Haematology ·(unknown), Alexandre Guy, Roseline d’Oiron, Annie Harroche, Aurélien Lebreton, (unknown), (unknown), (unknown)	2
3	Hémophilie acquise : quoi de neuf en 2024 ? 2024 ·La Revue de Médecine Interne ·H. Lévesque, Benoît Guillet, Roseline d’Oiron, Y. Benhamou	0
4	Intracranial hemorrhage before start of prophylaxis in children with hemophilia: incidence, timing, and potential for prevention 2024 ·Haematologica ·Nadine G. Andersson, (unknown), Giancarlo Castaman, Roseline d’Oiron, Gili Kenet, Christoph Königs, Christoph Male, Beatrice Nolan, Martin Olivieri, Fernando Campos Gomes Pinto, (unknown), Ester Zápotocká, (unknown)	1
5	Efficacy and safety of recombinant activated factor VII in Glanzmann thrombasthenia: A systematic literature review 2024 ·Haemophilia ·Paul Saultier, Michel Grino, Céline Falaise, Sophie Voisin, Cécile Lavenu‐Bombled, (unknown), Audrey Petit, Hélène Boutroux, Dominique Desprez, Mathieu Fiore, Roseline d’Oiron, Marie‐Christine Alessi	2
6	Outcomes and outcome measures 2024 ·Haemophilia ·Giancarlo Castaman, Víctor Jiménez‐Yuste, (unknown), Roseline d’Oiron	3
7	Dilemmas on emicizumab in children with haemophilia A: A survey of strategies from PedNet centres 2023 ·Haemophilia ·Susanna Ranta, Jayashree Motwani, Jan Blatný, (unknown), Manuel Carção, Hérvè Chambost, Carmen Escuriola, Kathelijn Fischer, Mutlu Kartal‐Kaess, (unknown), Gili Kenet, Christoph Male, Beatrice Nolan, Roseline d’Oiron, Martin Olivieri, Ester Zápotocká, Nadine G. Andersson, Christoph Königs	8
8	Modèle hub & spoke en France : organisation des soins et parcours des patients pour la thérapie génique de l’hémophilie 2023 ·Hématologie ·Yesim Dargaud, Antoine Rauch, Anne Lienhart, Laurent Frenzel, Virginie Barbay, (unknown), (unknown), (unknown), Roseline d’Oiron, Brigitte Pan‐Petesch, Geneviève Piétu, (unknown), Catherine Ternisien, B. Wibaut, Hérvè Chambost	3
9	PB0680 Clinical Characteristics, Therapy and Outcome of Children with Hemophilia B and Inhibitors: a PedNet Study 2023 ·Research and Practice in Thrombosis and Haemostasis ·(unknown), (unknown), Helen Pergantou, Roseline d’Oiron, Beatrice Nolan, C. Escuriola‐Ettingshausen, Kathelijn Fischer, Nadine G. Andersson, Heidi Glosli, María Román, Jayashree Motwani, Gili Kenet, Christoph Male	0
10	LB 01.1 Efanesoctocog Alfa Prophylaxis for Previously Treated Patients <12 Years of Age with Severe Hemophilia A 2023 ·Research and Practice in Thrombosis and Haemostasis ·Lynn Malec, Flora Peyvandi, Anthony K.C. Chan, (unknown), Bülent Zülfikar, Hang Yuan, Michael A. Simpson, María Román, Manuel Carção, Janice M. Staber, Amy L. Dunn, Sherry Chou, Roseline d’Oiron, Manuela Albisetti, Meaza Demissie, Elena Santagostino, (unknown), (unknown), Sriya Gunawardena, Karin Fijnvandraat	3
11	Ageing and women with bleeding disorders 2022 ·SHILAP Revista de lepidopterología ·Sheila Radhakrishnan, Roseline d’Oiron	1
12	A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH 2021 ·Journal of Thrombosis and Haemostasis ·Karin P. M. van Galen, Roseline d’Oiron, Paula James, Rezan A. Kadir, Peter A. Kouides, Roshni Kulkarni, Johnny Mahlangu, Maha Othman, Flora Peyvandi, (unknown), Rochelle Winikoff, Robert F. Sidonio	91
13	New Inhibitors in the Ageing Population: A Retrospective, Observational, Cohort Study of New Inhibitors in Older People with Hemophilia 2021 ·Thrombosis and Haemostasis ·Jan Astermark, Cihan Ay, Manuela Carvalho, Roseline d’Oiron, Philippe de Moerloose, Gerard Dolan, Pierre Fontana, Cédric Hermans, Pål André Holme, Όλγα Κατσαρού, Gili Kenet, Robert Klamroth, Maria Elisa Mancuso, (unknown), Ramiro Núñez, Ingrid Pabinger, Robert C. Tait, Paul van der Valk	0
14	Emicizumab Prophylaxis in Persons with Mild or Moderate Hemophilia A: Results from the Interim Analysis of the HAVEN 6 Study 2021 ·Blood ·Claude Négrier, Johnny Mahlangu, Michaela Lehle, Pratima Chowdary, Olivier Catalani, Víctor Jiménez‐Yuste, Benjamin M. Beckermann, Christophe Schmitt, Cédric Hermans, (unknown), Jerzy Windyga, Anna Kiialainen, Roseline d’Oiron, Paul Moorehead, (unknown), Amy D. Shapiro, Johannes Oldenburg	7
15	Clinical evaluation of bleeds and response to haemostatic treatment in patients with acquired haemophilia: A global expert consensus statement 2019 ·Haemophilia ·Andreas Tiede, Paul Giangrande, Jerome Teitel, Kagehiro Amano, Gary Benson, László Nemes, Víctor Jiménez‐Yuste, Roseline d’Oiron, (unknown), Craig M. Kessler	27
16	Common themes and challenges in hemophilia care: a multinational perspective 2018 ·Hematology ·Jayson Stoffman, Nadine G. Andersson, Brian R. Branchford, Katharine Batt, Roseline d’Oiron, Carmen Escuriola Ettingshausen, (unknown), Víctor Jiménez‐Yuste, Kaan Kavaklı, Maria Elisa Mancuso, Keiji Nogami, (unknown), Renyi Wu	14
17	Recombinant factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A 2014 ·Blood ·Thierry Calvez, Hérvè Chambost, Ségolène Claeyssens‐Donadel, Roseline d’Oiron, V. Goulet, Benoît Guillet, (unknown), (unknown), Chantal Rothschild, V. Roussel‐Robert, Christine Vinciguerra, Jenny Goudemand	108
18	Factor VIII bypasses CD91/LRP for endocytosis by dendritic cells leading to T-cell activation 2007 ·Haematologica ·Suryasarathi Dasgupta, Ana‐Maria Navarrete, Sébastien André, Bharath Wootla, Sandrine Delignat, Yohann Repessé, Jagadeesh Bayry, Antonino Nicoletti, Evgueni L. Saenko, Roseline d’Oiron, Marc Jacquemin, (unknown), Srini V. Kaveri, Sébastien Lacroix‐Desmazes	35
19	Response to DDAVP in mild/moderate haemophilia A patients according to the underlying Factor VIII genotype 2003 ·Journal of Thrombosis and Haemostasis ·Roseline d’Oiron, J. M. Lavergne, J Peynet, Marc Jacquemin, Benoît Guillet, Anne Rafowicz, Johannes Oldenburg, Renaud Lavend’homme, Kathelijne Peerlinck, Thierry Lambert, (unknown), Jean‐Marie Saint‐Remy, Jozef Vermylen, (unknown)	4
20	Mutations in the fibrinogen aalpha gene account for the majority of cases of congenital afibrinogenemia. 2000 ·Blood ·Marguerite Neerman‐Arbez, Philippe de Moerloose, Claire Bridel, (unknown), (unknown), Colette Rossier, Kathelijne Peerlinck, S. Claeyssens, (unknown), Roseline d’Oiron, Marie Dreyfus, (unknown), (unknown), Stylianos E. Antonarakis, Michael A. Morris	77

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact